HK1253301A1 - 制备胆汁酸衍生物的方法 - Google Patents

制备胆汁酸衍生物的方法 Download PDF

Info

Publication number
HK1253301A1
HK1253301A1 HK18112593.6A HK18112593A HK1253301A1 HK 1253301 A1 HK1253301 A1 HK 1253301A1 HK 18112593 A HK18112593 A HK 18112593A HK 1253301 A1 HK1253301 A1 HK 1253301A1
Authority
HK
Hong Kong
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
preparing
Prior art date
Application number
HK18112593.6A
Other languages
English (en)
Chinese (zh)
Inventor
R‧佩利恰里
A‧焦伊洛
Original Assignee
英特塞普特医药品公司
英特塞普特醫藥品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 英特塞普特医药品公司, 英特塞普特醫藥品公司 filed Critical 英特塞普特医药品公司
Publication of HK1253301A1 publication Critical patent/HK1253301A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK18112593.6A 2012-10-26 2016-02-24 制备胆汁酸衍生物的方法 HK1253301A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
US61/718,966 2012-10-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK16102102.3A Addition HK1214239B (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
HK1253301A1 true HK1253301A1 (zh) 2019-06-14

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112593.6A HK1253301A1 (zh) 2012-10-26 2016-02-24 制备胆汁酸衍生物的方法

Country Status (22)

Country Link
US (2) US9777038B2 (enExample)
EP (1) EP2912013B1 (enExample)
JP (1) JP6272888B2 (enExample)
KR (1) KR102068381B1 (enExample)
CN (2) CN108250264A (enExample)
AU (1) AU2013334122B2 (enExample)
BR (1) BR112015009395A2 (enExample)
CA (1) CA2889592A1 (enExample)
CY (1) CY1119731T1 (enExample)
DK (1) DK2912013T3 (enExample)
ES (1) ES2655034T3 (enExample)
HK (1) HK1253301A1 (enExample)
HU (1) HUE036887T2 (enExample)
IL (1) IL238454B (enExample)
MX (1) MX361653B (enExample)
NO (1) NO2968302T3 (enExample)
NZ (2) NZ745013A (enExample)
PL (1) PL2912013T3 (enExample)
PT (1) PT2912013T (enExample)
SG (1) SG11201503247UA (enExample)
SM (1) SMT201700602T1 (enExample)
WO (1) WO2014066819A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108250264A (zh) 2012-10-26 2018-07-06 英特塞普特医药品公司 制备胆汁酸衍生物的方法
LT3149019T (lt) 2014-05-29 2020-02-25 Bar Pharmaceuticals S.R.L. Cholano dariniai, skirti naudoti fxr ir tgr5/gpbar1 medijuojamų ligų gydymui ir (arba) prevencijai
EA033445B1 (ru) 2014-11-19 2019-10-31 Nzp Uk Ltd 5-бета-6-алкил-7-гидрокси-3-оновые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
WO2016079517A1 (en) 2014-11-19 2016-05-26 Dextra Laboratories Limited 6-alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the production of steroidal fxr modulators
EA033603B1 (ru) 2014-11-19 2019-11-08 Nzp Uk Ltd 6-альфа-алкил-6,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr
WO2016079519A1 (en) 2014-11-19 2016-05-26 Dextra Laboratories Limited 6.alpha.-alkyl-3,7-dione steroids as intermediates for the production of steroidal fxr modulators
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
EA036404B1 (ru) 2015-02-06 2020-11-06 Интерсепт Фармасьютикалз, Инк. Фармацевтические композиции для комбинированной терапии
KR20180052756A (ko) * 2015-09-24 2018-05-18 인터셉트 파마슈티컬즈, 인크. 담즙산 유도체 제조를 위한 방법 및 중간체
WO2017079062A1 (en) * 2015-11-06 2017-05-11 Intercept Pharmaceuticals, Inc. Methods for the preparation of obeticholic acid and derivatives thereof
US20200262865A1 (en) * 2016-02-15 2020-08-20 Alexander Khoruts Compositions and methods for treating clostridium associated diseases
KR102377338B1 (ko) 2016-04-13 2022-03-21 인터셉트 파마슈티컬즈, 인크. 암의 치료 방법
TW201738254A (zh) * 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
BR112019006242A2 (pt) * 2016-09-30 2019-06-18 Intercept Pharmaceuticals Inc formas cristalinas de um derivado de ácido biliar
AU2018307611A1 (en) 2017-07-24 2020-02-06 Intercept Pharmaceuticals, Inc. Isotopically labeled bile acid derivatives
EP3660030A4 (en) * 2017-07-26 2021-04-21 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. METHOD OF MANUFACTURING STEROID-DERIVATIVE FXR AGONISTS
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
CA3142358A1 (en) 2019-05-30 2020-12-03 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
EP4153589A4 (en) 2020-05-19 2024-06-12 Kallyope, Inc. AMPK ACTIVATORS
WO2021263039A1 (en) 2020-06-26 2021-12-30 Kallyope, Inc. Ampk activators
JP7583398B2 (ja) 2020-09-18 2024-11-14 ソウル大学校産学協力団 タウロデオキシコール酸ナトリウムの大量生産方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
DE60205891T2 (de) 2001-03-12 2006-06-22 Intercept Pharmaceuticals, Inc. Steroide als agonisten für fxr
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
PL2040713T3 (pl) * 2006-06-27 2014-11-28 Intercept Pharmaceuticals Inc Pochodne kwasów żółciowych jako ligandy FXR do zapobiegania lub leczenia chorób lub stanów, w których pośredniczy FXR
EP2303026B1 (en) * 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
US8796249B2 (en) * 2008-07-30 2014-08-05 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
ES2774368T3 (es) * 2008-11-19 2020-07-20 Intercept Pharmaceuticals Inc Moduladores de TGR5 y métodos de uso de los mismos
CN108250264A (zh) 2012-10-26 2018-07-06 英特塞普特医药品公司 制备胆汁酸衍生物的方法

Also Published As

Publication number Publication date
ES2655034T3 (es) 2018-02-16
BR112015009395A2 (pt) 2017-07-04
SG11201503247UA (en) 2015-06-29
NO2968302T3 (enExample) 2018-02-03
AU2013334122A1 (en) 2015-05-14
MX361653B (es) 2018-12-13
NZ707389A (en) 2018-08-31
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
DK2912013T3 (en) 2018-01-15
US20180079776A1 (en) 2018-03-22
CN105102425A (zh) 2015-11-25
AU2013334122B2 (en) 2017-11-02
KR20150074062A (ko) 2015-07-01
EP2912013A4 (en) 2016-06-01
PL2912013T3 (pl) 2018-05-30
US10202414B2 (en) 2019-02-12
SMT201700602T1 (it) 2018-03-08
IL238454A0 (en) 2015-06-30
KR102068381B1 (ko) 2020-01-20
WO2014066819A1 (en) 2014-05-01
US9777038B2 (en) 2017-10-03
PT2912013T (pt) 2018-01-03
CN108250264A (zh) 2018-07-06
US20150291653A1 (en) 2015-10-15
CY1119731T1 (el) 2018-06-27
JP2015533852A (ja) 2015-11-26
EP2912013A1 (en) 2015-09-02
JP6272888B2 (ja) 2018-01-31
CN105102425B (zh) 2018-04-10
MX2015005286A (es) 2015-10-29
EP2912013B1 (en) 2017-10-11
IL238454B (en) 2018-11-29
NZ745013A (en) 2019-08-30
CA2889592A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
HK1253301A1 (zh) 制备胆汁酸衍生物的方法
JP5202635B2 (ja) インテグラーゼ阻害剤の調製のためのプロセスおよび中間体
KR100555970B1 (ko) 2-아미노-1,3-프로판디올유도체의 제조방법
ES2717226T3 (es) Método de producción de beraprost
EP1806338B1 (en) Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof
CN102630226A (zh) 恩替卡韦的合成方法及其中间体化合物
KR20090066910A (ko) Ｌ-3-ｏ-치환-아스코르브산의 개선된 제조방법
WO2016004805A1 (zh) 一种艾日布林中间体的制备方法
TWI623521B (zh) 一種製備利馬前列素的中間體、其製備方法以及藉由其製備利馬前列素的方法
HK1214239B (en) Process for preparing bile acid derivatives
CN114605309B (zh) 一种氮杂双环衍生物的合成方法
US6753435B1 (en) Intermediates for vitamin D and processes for the preparation thereof
US20070129558A1 (en) Monohalogenovinyl vitamin d derivative compounds
JP2752489B2 (ja) 新規な大環状化合物及びその製造方法
JP2016501258A (ja) １０−デアセチルバッカチンｉｉｉからカバジタキセルを高収率で製造する新規方法及びそのための新規中間体
RO133248A2 (ro) Amine biciclo[2.2.1]heptanice protejate la grupa hidroxil
KR19980065189A (ko) 무스콘의 신규합성중간체 및 그의 제조방법
JP2008255049A (ja) 有機アンチモン化合物、その製造方法及びこれを用いたセンサー
PL213059B1 (pl) Chiralny karboksyester dimetylocyklopropanui sposób jego wytwarzania
TW201920106A (zh) 製備１－［６－鹵－３－吡啶基］酮之方法
CN102690254A (zh) 辛伐他汀铵盐中间体及其制备方法
KR20060094553A (ko) 2＇,2＇-디플루오로뉴글레오시드 중간체의 제조방법
PL197215B1 (pl) Nowy chiralny bromospirolakton karanu i sposób jego wytwarzania
JPH01100195A (ja) １α，２４―ジヒドロキシコレステロール類の製造法
KR19980065188A (ko) 무스콘의 신규합성중간체 및 그의 제조방법